People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EndoShape, Inc. | — | Other Health Care | Series A | $28.7M | $80.7M | 2011 |
| EnteroTrack, LLC | — | Biotechnology | Series A | $4.9M | $109.9M | 2014 |
Robin Shandas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robin Shandas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Robert Kline | 1 | 6 |
| Mark Lupa | 1 | 5 |
| Bryan Grulke | 1 | 4 |
| Shawn Fojtik | 1 | 4 |
| Lee Geist | 1 | 2 |
| William Aldrich | 1 | 2 |
| Jeffrey Harrington | 1 | 1 |
| Donald Geer | 1 | 1 |
| Jeff Castleberry | 1 | 1 |
| Lindsay Carter | 1 | 1 |
| James McGuckin | 1 | 1 |
| Steven Ackerman | 1 | 1 |
| Glenn Furuta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.